Kim Schelble Joins Vygon as Senior VP of Sales and Marketing, North America

Vygon North America, a wholly-owned subsidiary of Vygon SA, has appointed Kim Schelble as senior vice president of North American sales and marketing.
 
In this key commercial role, Kim will serve on the subsidiary’s executive leadership team and be responsible for growing the reach and brand promise to more than 220 children’s hospitals, 5,500 hospitals, 1,000 integrated delivery networks and 600 group purchasing organizations in the United States and Canada.
 
“We are excited to welcome Kim to our leadership team,” Vygon North America CEO Peter Ciriello said. “Kim brings 18 consecutive years of medical device experience, has launched over 35 new Class II and Class III PMA medical device products, and has eminence in vascular access, neonatal/pediatrics and peripheral vascular. I look forward to his strategic leadership and commitment towards executing on our long-range strategic plan.”
 
Kim previously worked as vice president and general manager vascular access at Smiths Medical ASD, where he supervised the largest business unit with its $430 million in annual sales. Kim led the Vascular Access Business Unit leadership team and was head of global marketing. More recently, he was vice president and managing director at Poly Medicure Ltd.; there, he established the company’s North American subsidiary; managed sales and marketing efforts for various vascular, respiratory, and critical care products in both human health and animal health; gaining U.S. Food and Drug Administration 510(k) product clearances; and signed up globally recognized distributors.
 
Kim has worked at global strategic medical device companies including Medtronic Spine & Biologics, Medtronic plc, and Covidien plc. His experience also includes stints at novel private equity-backed startups including DFine Inc. and Cerapedics Inc. in various director and vice president commercial roles.
 
“I am very excited to join Peter and the Vygon North America leadership team, to grow and deliver value to U.S. and Canadian hospitals and integrated delivery networks with our neonatal, pediatrics, vascular access, and anesthesia/respiratory products,” Schelble stated. “I have been impressed with the team that Peter has built and look forward to providing meaningful solutions to improve the delivery of medicine and critical care to some of the most vulnerable and deserving patients with our hospital and IDN partners.”
 
Kim earned an MBA in finance and marketing from the UCLA Anderson School of Management and a bachelor of science degree in commerce (B.S.C) with a concentration in marketing from Santa Clara University in California.
 
Kim began his career at Deloitte & Touche as an analyst and later an associate in the firm’s IPO Center of Excellence and Venture Capital Services Group. He has carried on the tradition helping medical device companies with capital raising and access to capital within the medical device sector.
 
Vygon SA (Vygon) is a medical specialty company that designs, manufactures, and markets single-use medical and surgical products. The company offers products in various specialties and therapeutic areas such as pediatrics, neonatology, support for post-operative pain relief, anesthesia, emergency and intensive care units, vascular access, surgery, and home care, among others. The company manufactures its products at plants in Europe, Mauritius, Colombia, and the United States, and offers its products to healthcare professionals in hospitals and to independent practitioners. The company markets products directly and through a network of distributors across the Americas, Asia, Europe, the Middle East, and Africa. Vygon is headquartered in Ecouen, France.